Skip to main content

Table 1 Baseline characteristics of studies included in the meta-analysis

From: Influence of viral hepatitis status on prognosis in patients undergoing hepatic resection for hepatocellular carcinoma: a meta-analysis of observational studies

Author

Year

Country

Group

No. of

patients

Male/

Female

Mean age

(years)

Mean follow-up

(months)

Takenaka [30]

1995

Japan

B-HCC

C-HCC

30

96

22/8

77/19

57.0 ± 9.4

61.7 ± 6.9

--

--

Miyagawa [31]

1996

Japan

B-HCC

C-HCC

NBNC

32

124

19

21/11

96/28

15/4

52.1 ± 12.4

63.9 ± 7.0

62.2 ± 11.8

--

--

--

Yamanaka [3]

1997

Japan

B-HCC

C-HCC

NBNC

27

151

20

24/3

125/26

18/2

51 ± 10

63 ± 6.3

63 ± 6.4

--

--

--

Wu [26]

1999

Taiwan

B-HCC

C-HCC

NBNC

131

70

40

110/21

56/14

29/11

54.3 ± 1.1

64.1 ± 1.1

68.9 ± 1.9

34.5*&

Shiraishi [32]

1999

Japan

B-HCC

C-HCC

NBNC

11

21

12

--

--

--

54.0 ± 3.2

62.0 ± 1.8

63.0 ± 4.1

--

--

--

Lee [4]

2000

Taiwan

B-HCC

C-HCC

NBNC

133

66

30

112/21

48/18

20/10

49.4 ± 12.7

61.7 ± 9.2

54.3 ± 13.3

23.5 ± 16.3 &

Noguchi [33]

2000

Japan

B-HCC

C-HCC

NBNC

44

232

13

34/10

172/60

12/1

51.6 ± 8.4

65.0 ± 7.0

60.9 ± 6.7

--

--

--

Roayaie [34]

2000

United States

B-HCC

C-HCC

21

24

10/11

17/7

54.3 ± 15.3

63.4 ± 8.5

20.3*&

Ahmad [35]

2001

United States

B-HCC

C-HCC

NBNC

18

44

15

13/5

34/10

6/9

60

61

63

30*

27*

33*

Chen [36]

2001

Taiwan

B-HCC

C-HCC

211

59

190/21

47/12

57.6 ± 12.7

66.9 ± 8.2

--

--

Wakai [37]

2003

Japan

B-HCC

C-HCC

NBNC

32

55

24

20/12

46/9

18

52.5 (16-77)*

64 (46-78)

68 (45-79)

75*&

Pawlik [5]

2004

Multi center

B-HCC

C-HCC

NBNC

163

79

126

137/26

48/31

90/36

60*

60

51

33*&

Uchiyama [39]

2005

Japan

B-HCC

C-HCC

NBNC

25

72

24

18/7

48/24

18/6

54 ± 10

64 ± 9

65 ± 8

--

--

--

Yokoi [38]

2005

Japan

B-HCC

C-HCC

NBNC

25

116

13

19/6

95/21

10/3

57 (32-74)*

64 (46-85)

58 (28-72)

--

--

--

Sasaki [40]

2006

Japan.

B-HCC

C-HCC

66

351

49/17

268/83

> 65 (n = 5)

> 65 (n = 114)

132*

121.2*

Li [27]

2007

China

B-HCC

C-HCC

NBNC

251

75

54

212/39

62/13

44/10

51.2 ± 4.2

63.2 ± 7.3

67.1 ± 5.7

48.3* &

Nanashima [28]

2007

Japan

B-HCC

C-HCC

NBNC

76

124

29

61/15

99/25

21/8

59 ± 11

67 ± 7

65 ± 8

--

--

--

Kondo [41]

2008

Japan

B-HCC

C-HCC

NBNC

78

127

60

58/20

94/33

43/17

54.7 ± 11.6

67.2 ± 6.7

67.9 ± 10.3

26*&

Cescon [29]

2009

Italy

B-HCC

C-HCC

NBNC

25

130

35

24/1

90/40

30/5

60.2 ± 9.8

65.2 ± 8.1

64.2 ± 9.1

30*&

Kao [42]

2011

Taiwan

B-HCC

C-HCC

609

206

516/93

147/59

56.3 ± 13.5

67.2 ± 9.1

40.6*&

  1. HCC = hepatocellular carcinoma; B-HCC = hepatitis B-related hepatocellular carcinoma; C-HCC = hepatitis C-related hepatocellular carcinoma; NBNC-HCC = no infection of HBV or HCV related hepatocellular carcinoma; * = median; & = entire group